NTRA Q1 2022 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$29B

Q1 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$194M+27.5% YoY

Gross Profit

$91M46.8% margin

Operating Income

-$137M-70.6% margin

Net Income

-$139M-71.4% margin

EPS (Diluted)

$-1.45

QoQ Revenue Growth

+12.2%

Cash Flow

Operating Cash Flow

-$137M

Free Cash Flow

-$153M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$602M

Stockholders' Equity

$542M

Cash & Equivalents

$158M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$194M	$152M	+27.5%
Gross Profit	$91M	$86M	+6.3%
Operating Income	-$137M	-$63M	-117.6%
Net Income	-$139M	-$64M	-117.1%

Revenue Segments

Product

$190M98%

Licensing and other

$4M2%

Geographic Segments

United States

$187M96%

Europe, Middle East, India, Africa

$4M2%

Asia Pacific and Other

$2M1%

Americas, excluding U.S.

$741,0000%